Glipizide: an oral hypoglycemic drug.

G. Wensing

Abstract:

What problem does this paper attempt to address?

Transforming Healthcare with AI: Promises, Pitfalls, and Pathways Forward

Ali Shuaib

DOI: https://doi.org/10.2147/ijgm.s449598

IF: 2.145

2024-05-02

International Journal of General Medicine

Abstract:Ali Shuaib Biomedical Engineering Unit, Department of Physiology, Faculty of Medicine, Kuwait University, Safat, 13110, Kuwait Correspondence: Ali Shuaib, Biomedical Engineering Unit, Department of Physiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat, 13110, Kuwait, Email This perspective paper provides a comprehensive examination of artificial intelligence (AI) in healthcare, focusing on its transformative impact on clinical practices, decision-making, and physician-patient relationships. By integrating insights from evidence, research, and real-world examples, it offers a balanced analysis of AI's capabilities and limitations, emphasizing its role in streamlining administrative processes, enhancing patient care, and reducing physician burnout while maintaining a human-centric approach in medicine. The research underscores AI's capacity to augment clinical decision-making and improve patient interactions, but it also highlights the variable impact of AI in different healthcare settings. The need for context-specific adaptations and careful integration of AI technologies into existing healthcare workflows is emphasized to maximize benefits and minimize unintended consequences. Significant attention is given to the implications of AI on the roles and competencies of healthcare professionals. The emergence of AI necessitates new skills in data literacy and technology use, prompting a shift in educational curricula towards digital health and AI training. Ethical considerations are a pivotal aspect of the discussion. The paper explores the challenges posed by data privacy concerns, algorithmic biases, and ensuring equitable access to AI-driven healthcare. It advocates for the development of comprehensive ethical frameworks and ongoing research to guide the responsible use of AI in healthcare. Conclusively, the paper advocates for a balanced approach to AI adoption in healthcare, highlighting the importance of ongoing research, strategic implementation, and the synergistic combination of human expertise with AI technologies for optimal patient care. Keywords: artificial intelligence, healthcare transformation, AI integration strategies The healthcare industry faces pressing challenges, including inefficient systems, suboptimal decisions, and strained physician-patient relationships. 1 This situation has led to substantial interest in leveraging artificial intelligence (AI) to improve healthcare quality, access, and delivery. AI collectively refers to computational techniques that enable systems to perform tasks that normally require human intelligence, such as visual perception, speech recognition, and decision-making. 2 By analyzing complex medical datasets beyond human capabilities, AI has the potential to transform clinical care and healthcare operations. However, realizing AI's full potential in enhancing health outcomes necessitates grappling with the complex practical barriers and risks involved in integrating these rapidly evolving technologies into embedded healthcare workflows, systems, and practices. For instance, AI-powered mobile health applications have the potential to provide vital healthcare information and services in remote areas, addressing the challenges of diverse healthcare systems globally. 3 These applications can leverage machine learning, cloud computing, and wearable technologies to gather and analyze health data, detect diseases, and improve healthcare prediction systems. 4 The integration of health services into technology-based systems, such as mobile health applications, offers convenience and better health services for individuals and healthcare personnel. 5 Additionally, the use of AI algorithms in healthcare can aid in diagnosis, drug development, personalized medicine, patient monitoring, and care. 6 However, it is important to consider the positive and negative effects of mobile health applications, especially regarding privacy and trust. 7 By developing adaptable AI solutions that consider the challenges and needs of diverse healthcare systems, as discussed recently in-depth by Wang and Preininger 8 and Chakraborty et al 9 these applications can have a transformative impact on healthcare access and outcomes globally. Understanding and addressing these varied global needs is crucial for the responsible and effective implementation of AI in healthcare worldwide. This perspective paper aims to provide an in-depth and balanced analysis of the major opportunities as well as the risks and challenges associated with effectively incorporating AI capabilities into healthcare environments. It integrates insights from emerging evidence regarding AI applications in medicine, drawing from research studies, expert opinions, and real-world examples of AI implementation in -Abstract Truncated-

medicine, general & internal
Exploring the Potential of Artificial Intelligence in Healthcare: Possibilities and Challenges

M. S. Eshwar

DOI: https://doi.org/10.55041/isjem00408

2023-04-22

Abstract:Artificial intelligence (AI) has the potential to revolutionize healthcare by offering personalized, accurate, and innovative solutions, but it poses challenges such as data privacy, regulatory compliance, and ethical considerations. This research paper provides a comprehensive review of the current state of AI in healthcare, its applications, benefits, challenges, and future prospects. The report emphasizes how AI has the potential to revolutionise healthcare delivery by enhancing patient outcomes, diagnosis, and treatment while lowering costs and increasing efficiency. With the ability to analyze vast amounts of medical data quickly and accurately, AI has enormous potential to provide personalized and timely care to patients. To ensure the appropriate and ethical use of AI in healthcare, however, there are important ethical and regulatory obstacles that must be addressed. Keywords: Artificial Intelligence, Healthcare

Computer Science,Medicine
Association of serum lipid profiles with depressive and anxiety disorders in menopausal women.

Chien-Chin Chen,Tiao-Lai Huang

2006-05-01

Abstract:BACKGROUND Several studies have investigated the relationships of lipid levels with depressive and anxiety disorders, and their results revealed an association between low cholesterol and higher levels of depressive symptoms in young, middle-aged, and postpartum women. However, few studies have explored this relationship in menopausal women. Hence, in this study of menopausal Taiwanese women, we attempted to determine the correlation of depressive and anxiety disorders with serum lipid profiles. METHODS This was a cross-sectional study covering a 2-year period. Sixty-nine menopausal women who visited the gynecologic outpatient department of our hospital were enrolled. Psychiatric diagnoses were made using the semi-structured clinical interview for the Diagnostic and Statistical Manual (DSM-IV) criteria. Blood samples for serum lipid profiles were simultaneously collected. Data were analyzed using analysis of co-variance (ANCOVA) adjusted for age and body mass index (BMI). RESULTS Total cholesterol (TC) and low-density lipoprotein (LDL) were higher in postmenopausal women than in perimenopausal women, but this was not true for triglyceride (TG), high-density lipoprotein (HDL), very-low-density lipoprotein (VLDL), the TC/HDL ratio, or the LDL/HDL ratio. However, when peri- and postmenopausal women were categorized into normal controls and those having anxiety disorders and depressive disorders, no significant differences were found in lipid concentrations of TG, TC, HDL, VLDL, LDL, TC/HDL, or LDL/HDL among the 3 groups. CONCLUSIONS Although these results do not suggest that serum lipid profiles can be used as biological markers to distinguish depressive or anxiety disorders in menopausal women, larger samples are required to prove such results in the future.
Legal and Ethical Challenges of Artificial Intelligence Applications in Healthcare

Shahriar Eslamitabar,Ehsan Lame,Ahmad Rouzbahani,Zohre Roozbahani

DOI: https://doi.org/10.18502/htaa.v7i4.14653

2024-01-07

Health Technology Assessment in Action

Abstract:Artificial intelligence (AI) has become an integral part of modern healthcare, with its algorithms and other AI-enabled applications supporting medical professionals in clinical and research settings. The digital revolution is transforming the way we approach medical care. Currently, numerous AI products have been developed to cover various aspects of healthcare, such as predicting the risk of acute and chronic diseases (e.g., cardiovascular risk, gastrointestinal bleeding, and eye conditions) and forecasting cancer risk, among other cases. Artificial intelligence has the capacity to revolutionize the utilization of health information collected in datasets. However, the specific characteristics of AI, including vagueness, complexity, data dependency, and automated behavior, can pose potential risks to users’ fundamental rights and safety. Therefore, it is crucial to recognize and mitigate these risks and provide legal solutions for any harm resulting from these risks. In the realm of healthcare, AI plays a pivotal role in advancing reliable prediction capabilities. Consequently, the storage and processing of data are imperative for emerging diagnostic and decision-making technologies. Nevertheless, these advances also introduce privacy risks, raising significant legal challenges for medical institutions. Understanding the various levels of these risks assists healthcare professionals and institutions in managing these challenges and complying with regulations. This descriptive research article comprehensively examines and implements the regulatory frameworks governing the United States and the European Union. Additionally, it draws upon documented research in this field to discuss the utilization of AI in healthcare, along with the associated legal issues, including informed consent and malpractice.
Artificial Intelligence in Health Sector: Current Status and Future Perspectives

Phani Teja Nallamothu,Kimberly Morton Cuthrell

DOI: https://doi.org/10.9734/ajrcos/2023/v15i4325

2023-04-15

Asian Journal of Research in Computer Science

Abstract:The developing fields of artificial intelligence (AI)/ machine learning (ML) offer a significant potential to improve healthcare services. Many areas of clinical practice, scientific research, and healthcare management have included AI/ML techniques. Screening and daily fitness monitoring, diagnostic services in gastroenterology, pathology, and radiology, as well as support for clinical decision-making and palliative care, are the main categories involved. However, there are significant obstacles to the widespread use of AI/ML in healthcare, including higher installation and maintenance costs, potentially harmful medical mistakes, a lack of ethical frameworks for AI, unemployment, and reduced capacity building within the human workforce. Many business initiatives have now been created in the field of healthcare AI/ML innovation. They offer everything from advanced diagnostics to vitals monitoring in their products and services. In short, AI/ML may be extremely important in addressing the difficulties with complexity and the explosion of data in the healthcare system. AI/ML is a component of contemporary healthcare, and its further adoption is contingent on thoroughly addressing pertinent issues.
Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives

Molly Bekbolatova,Jonathan Mayer,Chi Wei Ong,Milan Toma

DOI: https://doi.org/10.3390/healthcare12020125

2024-01-06

Health Care

Abstract:Artificial intelligence (AI) has emerged as a crucial tool in healthcare with the primary aim of improving patient outcomes and optimizing healthcare delivery. By harnessing machine learning algorithms, natural language processing, and computer vision, AI enables the analysis of complex medical data. The integration of AI into healthcare systems aims to support clinicians, personalize patient care, and enhance population health, all while addressing the challenges posed by rising costs and limited resources. As a subdivision of computer science, AI focuses on the development of advanced algorithms capable of performing complex tasks that were once reliant on human intelligence. The ultimate goal is to achieve human-level performance with improved efficiency and accuracy in problem-solving and task execution, thereby reducing the need for human intervention. Various industries, including engineering, media/entertainment, finance, and education, have already reaped significant benefits by incorporating AI systems into their operations. Notably, the healthcare sector has witnessed rapid growth in the utilization of AI technology. Nevertheless, there remains untapped potential for AI to truly revolutionize the industry. It is important to note that despite concerns about job displacement, AI in healthcare should not be viewed as a threat to human workers. Instead, AI systems are designed to augment and support healthcare professionals, freeing up their time to focus on more complex and critical tasks. By automating routine and repetitive tasks, AI can alleviate the burden on healthcare professionals, allowing them to dedicate more attention to patient care and meaningful interactions. However, legal and ethical challenges must be addressed when embracing AI technology in medicine, alongside comprehensive public education to ensure widespread acceptance.

health care sciences & services,health policy & services
What kills patients with rheumatoid arthritis?

C. Kelly,J. Hamilton

DOI: https://doi.org/10.1093/RHEUMATOLOGY/KEL332

2006-07-28

Rheumatology

Abstract:Patients with rheumatoid arthritis (RA) die at a younger age than their peers in most hospital series [1], while an increase in standardized mortality rate (SMR) has not been a consistent feature in recent studies of RA patients from date of diagnosis (inception cohorts) [2]. The reasons for this apparent discrepancy are likely to be the presence of more severe disease in hospitalbased series and the advent of earlier and more effective treatment in recent years. However, an increased mortality from vascular disease in RA has been consistently reported in both established and inception studies [1, 3], and an increased SMR for respiratory disease and lymphoreticular cancers has also been recognized in most series. A detailed study in this month’s issue addresses the important question of whether patients with RA treated early and actively with disease-modifying anti-rheumatic drugs (DMARDs) still have increased mortality rates [4]. The study assesses the effect of modern out-patient intervention on all-cause mortality in a large inception cohort over the first 7 yrs of their disease, and examines whether this relates to disease severity or duration. Detailed assessment of the causes of death offers new insights into the relevance of both cardiovascular and respiratory contributions to mortality and attempts to identify risk factor profiles. Although increasing age and male gender have been recognized as predictors for an earlier death in RA, few other clues as to an individual’s risk of premature death have been identified. However, recent work has shown direct links between rheumatoid disease activity, increased comorbidity and early death [5, 6]. The Early Rheumatoid Arthritis Study (ERAS) group [4] reports on 1429 patients recruited within 2 yrs of diagnosis over the 11 yrs from 1986. Although 84% received therapy with DMARDs, the all-cause SMR was significantly raised. After increased age, the odds ratios for death were most elevated in those patients with extra-articular disease and in those with established comorbidity. Early death was most often due to cardiovascular disease or interstitial pulmonary fibrosis, although other vascular and respiratory causes were also over-represented. Cardiovascular disease accounted for 31% of all deaths while pulmonary problems (including respiratory infection and lung cancer) were responsible for almost 29%. Ischaemic heart disease (IHD) accounted for a quarter of all deaths and carried an SMR of 1.49. It was also the most common cause of death at a young age and had a worse prognosis than in patients without RA. There was a relationship between disease activity as assessed by erythrocyte sedimentation rate (ESR) and probability of death from IHD, a finding consistent with previous reports linking increased markers of inflammation with coronary artery disease [7]. This suggests that DMARD therapy should protect RA patients from developing IHD, and reinforces the need for such therapy to be commenced early in the disease and used aggressively where possible, aiming for remission within the first year of disease. The link between cardiac disease and other therapeutic agents is less clear. Oral steroids did not have any clear effect on cardiovascular mortality but high-dose or long-term therapy might be expected to adversely affect the traditional risk factor profile by increasing blood pressure and body mass index and worsening the lipid profile. The influence of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular health has been much debated lately. COX-2 drugs especially have been linked with an increase in vascular events (in the order of one additional event per 100 patient years), with the data leading to the ultimate withdrawal of rofecoxib. However, a recent major meta analysis of the data on all NSAIDs report that many nonselective agents such as ibuprofen and diclofenac are also associated with an increased risk of adverse cardiovascular events, although it was unclear as to whether this effect was linked to dose or duration of treatment [8]. Perhaps the most striking aspect of the ERAS report is the high mortality resulting from interstitial pulmonary fibrosis (IPF). This accounted for 6% of all deaths and exceeded the combined number of deaths from all other extra-articular features of RA. It especially affected those patients with a younger age at onset of RA. Given that features of IPF can be shown using highresolution computed tomography (HRCT) in up to 20% of RA patients [9], this is a significant finding. Although there is some evidence that the natural history of IPF in RA is better than that in cryptogenic fibrosis [10], there is a paucity of data in the literature on this condition. Recent concern has been expressed that the natural history is worse in patients on biological agents following reports linking death from accelerated IPF in patients receiving etanercept, infliximab or adalimumab. Indeed the BSRBR confirms that deaths from IPF are increased nearly 3fold in patients on anti-tumor necrosis factor (anti-TNF) agents when compared with controls on methotrexate. Methotrexate itself has not been shown to cause deterioration in lung function in large series of patients, but nor does it appear to have any beneficial effect on IPF. Its ability to cause pneumonitis places patients with reduced respiratory reserve at increased risk, and is a cogent argument for the assessment of pulmonary function prior to its use, with patients demonstrating a restrictive defect requiring greater definition using HRCT to identify those patients with significant underlying lung disease [11]. Perhaps the choice of DMARD in patients with proven IPF should be driven by consideration of the lung disease as much as by the degree of articular involvement? Drug-related deaths were reported in the ERAS report, and these related largely to the use of NSAIDs which were responsible for eight fatalities resulting from upper gastrointestinal haemorrhage or perforation. Most of these patients had been on long-term therapy with NSAIDs but some had only recently commenced these agents. There is good evidence to implicate Helicobacter pylori infection in upper gastrointestinal ulceration, and recent work has shown that the presence of this bacterial agent together with NSAID exposure in RA patients greatly increases their risk of having an endoscopically visualized peptic ulcer [12]. Drugs may also have contributed to the greatly increased SMR (350) recorded for renal failure in the study, given the propensity of NSAIDs to precipitate renal failure in patients with reduced glomerular filtration rates. Taking these findings together with those linking NSAIDs with increased cardiovascular mortality, it is time for rheumatologists and primary care practitioners to reduce dependence on NSAIDs, particularly in patients with a high 10-yr risk of cardiovascular disease, a history of dyspepsia or evidence of reduced renal function. The risk of death as a result of infection is increased in patients with RA and this is reflected in the ERAS report. Septicaemia had Rheumatology 2007;46:183–184 doi:10.1093/rheumatology/kel332 Advance Access publication 26 September 2006
Artificial Intelligence in Healthcare With an Emphasis on Public Health

Abhay B Mudey,Aditya S Dhonde,Mandar V Chandrachood

DOI: https://doi.org/10.7759/cureus.67503

2024-08-22

Cureus

Abstract:Artificial Intelligence (AI), since its inception, has revolutionized multiple sectors, including healthcare in the 20th century, and has applications in data interpretation, leading to advancements in diagnostics, therapeutics, and clinical decision-making. AI is referred to as the capability of a software program to accurately analyze extrinsic information and utilize it for accomplishing desired goals and objectives through appropriate flexibility. It makes use of complicated operative algorithms to excel in human learning potential with overwhelming abilities to interpret large sets of data. The scope and implications of AI are consistently amplifying and have contributed significantly in nearly all phases of human life, especially healthcare. The integration of AI-related advancements would surely ameliorate the delivery of healthcare by allowing its accessibility, affordability, and level of care provided. For instance, reading CT scans is feasible by both AI as well as a radiologist. The screening of Tuberculosis is possible through AI via Chest X-rays with comparability in performance as molecular testing and mammography scans can predict the onset of breast cancer prior to the appearance of the ocular signs. Therefore, AI has been realized as one of the core areas by researchers and the government for public health benefit. For the same reason, it is imperative to adopt an ethically sound policy framework for guiding the further development of AI-based technologies and their application in public health. AI-based interpretations themselves cannot be fully trusted for their diagnostic decisions and judgements, and hence, it is vital to assess their accountability through all phases of development and deployment in the field of health. This article emphasizes the advancements in AI-based technologies, their assistance in public healthcare delivery systems, and their merits and demerits. It also explores the various ethical directives that need to be adhered to while utilizing it for public health welfare.
Artificial Intelligence in Medicine: Revolutionizing Healthcare for Improved Patient Outcomes

Varshil Mehta

DOI: https://doi.org/10.32892/jmri.292

2023-06-03

Journal of Medical Research and Innovation

Abstract:Introduction: Artificial intelligence (AI) has emerged as a groundbreaking technology with the potential to transform various sectors, and the field of medicine is no exception. With its ability to process vast amounts of data and perform complex tasks, AI has begun to revolutionize healthcare, offering promising avenues for diagnosis, treatment, and patient care. In this editorial article, we will explore the significant impact of AI in medicine, highlighting its potential benefits and the challenges that lie ahead. AI-Driven Diagnosis One of the most remarkable applications of AI in medicine is its capacity to assist in accurate and efficient diagnosis. By leveraging machine learning algorithms, AI systems can analyze medical imaging, such as X-rays, MRIs, and CT scans, with a level of precision that rivals human experts. Studies have demonstrated the effectiveness of AI in detecting various conditions, including lung cancer, cardiovascular diseases, and neurological disorders, leading to earlier and more accurate diagnoses. For instance, a study published in Nature Medicine by McKinney et al. revealed that an AI model trained on a large dataset of mammograms outperformed radiologists in breast cancer detection. The AI system achieved a lower false-negative rate and reduced the number of false positives, thereby potentially reducing unnecessary biopsies [1]. Similarly, a study by Esteva et al., showed that a deep learning algorithm outperformed dermatologists in diagnosing skin cancer based on images [2]. Such advancements in AI-driven diagnosis hold immense promise for improving patient outcomes and reducing healthcare costs. Personalized Treatment and Precision Medicine AI has also opened doors to personalized treatment strategies, enabling healthcare professionals to tailor therapies to individual patients. By analyzing vast amounts of patient data, including genetic information, medical history, and treatment outcomes, AI algorithms can identify patterns, predict responses to specific treatments, and recommend personalized interventions. This approach, known as precision medicine, has the potential to revolutionize disease management. An example of AI's impact on precision medicine is showcased in the work of Poplin et al. The study demonstrated how a deep learning algorithm could predict the onset of cardiovascular events by analyzing electronic health records. The algorithm outperformed traditional risk models by incorporating a broader range of patient data, allowing for more accurate and timely interventions to prevent adverse events [3]. Similarly, Obermeyer et al., demonstrated that an AI model outperformed traditional methods in predicting acute kidney injury in hospitalized patients [4] while a study by Che et al., demonstrated the effectiveness of an AI model in predicting sepsis, allowing for early intervention and improved patient outcomes [5]. Enhanced Clinical Decision-Making and Workflow AI has the capacity to enhance clinical decision-making by assisting healthcare providers in analyzing complex data and generating evidence-based recommendations. AI systems can process and interpret vast amounts of medical literature, patient records, and clinical guidelines, providing healthcare professionals with timely insights and decision support. This augmentation of human expertise can lead to more accurate diagnoses, improved treatment plans, and enhanced patient care. A notable example is the work of Rajkomar et al., published in The New England Journal of Medicine. The authors developed an AI algorithm capable of predicting patient deterioration within the next few hours, based on electronic health record data. By alerting healthcare providers in advance, this AI system helped to prevent adverse events and facilitated proactive interventions [6]. Drug Discovery and Clinical Research The drug discovery and development process is notoriously expensive and time-consuming. AI has the potential to accelerate this process by analyzing vast amounts of biomedical literature, genomic data, and clinical trial outcomes. Machine learning models can identify potential drug targets, predict drug toxicity, and optimize drug formulations. In fact, a study by Aliper et al., demonstrated that an AI system outperformed human researchers in designing new drugs to target age-related diseases [7]. Virtual Assistants and Telemedicine AI-powered virtual assistants and chatbots are transforming the way patients interact with healthcare providers. These virtual assistants can provide instant medical advice, answer queries, and triage patients based on their symptoms. Furthermore, telemedicine platforms integrated with AI algorithms can enhance remote patient monitoring, enabling healthcare professionals to monitor patients' vital signs and provide timely interventions [8,9]. Challenges and Ethical Considerations While the potential benefits of AI in medicine are substantial, it is important to address the challenges and ethical considerations associated with its implementation. Privacy and data security remain critical concerns when handling vast amounts of patient data. Maintaining patient confidentiality and ensuring secure data sharing frameworks must be prioritized to protect patient privacy. Moreover, the need for transparency and interpretability of AI algorithms is vital to build trust between healthcare professionals and AI systems. Understanding how AI arrives at its recommendations or diagnoses is crucial for healthcare providers to make informed decisions and ensure accountability. Conclusion: Artificial intelligence holds tremendous potential to revolutionize healthcare and improve patient outcomes. From enhancing diagnostic accuracy to enabling personalized treatment strategies and augmenting clinical decision-making, AI is transforming the field of medicine. However, to fully realize the benefits, it is essential to address the challenges surrounding privacy, data security, and algorithm transparency. By leveraging the power of AI responsibly, healthcare providers can usher in a new era of precision medicine, advancing the quality and effectiveness of patient care.
Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges

Harshana Liyanage,Siaw-Teng Liaw,Jitendra Jonnagaddala,Richard Schreiber,Craig Kuziemsky,Amanda L Terry,Simon de Lusignan

DOI: https://doi.org/10.1055/s-0039-1677901

2019-04-25

Yearbook of Medical Informatics

Abstract:Background: Artificial intelligence (AI) is heralded as an approach that might augment or substitute for the limited processing power of the human brain of primary health care (PHC) professionals. However, there are concerns that AI-mediated decisions may be hard to validate and challenge, or may result in rogue decisions. Objective: To form consensus about perceptions, issues, and challenges of AI in primary care. Method: A three-round Delphi study was conducted. Round 1 explored experts’ viewpoints on AI in PHC (n=20). Round 2 rated the appropriateness of statements arising from round one (n=12). The third round was an online panel discussion of findings (n=8) with the members of both the International Medical Informatics Association and the European Federation of Medical Informatics Primary Health Care Informatics Working Groups. Results: PHC and informatics experts reported AI has potential to improve managerial and clinical decisions and processes, and this would be facilitated by common data standards. The respondents did not agree that AI applications should learn and adapt to clinician preferences or behaviour and they did not agree on the extent of AI potential for harm to patients. It was more difficult to assess the impact of AI-based applications on continuity and coordination of care. Conclusion: While the use of AI in medicine should enhance healthcare delivery, we need to ensure meticulous design and evaluation of AI applications. The primary care informatics community needs to be proactive and to guide the ethical and rigorous development of AI applications so that they will be safe and effective.

English Else
Patients' Perceptions Toward Human-Artificial Intelligence Interaction in Health Care: Experimental Study

Pouyan Esmaeilzadeh,Tala Mirzaei,Spurthy Dharanikota

DOI: https://doi.org/10.2196/25856

2021-11-25

Abstract:Background: It is believed that artificial intelligence (AI) will be an integral part of health care services in the near future and will be incorporated into several aspects of clinical care such as prognosis, diagnostics, and care planning. Thus, many technology companies have invested in producing AI clinical applications. Patients are one of the most important beneficiaries who potentially interact with these technologies and applications; thus, patients' perceptions may affect the widespread use of clinical AI. Patients should be ensured that AI clinical applications will not harm them, and that they will instead benefit from using AI technology for health care purposes. Although human-AI interaction can enhance health care outcomes, possible dimensions of concerns and risks should be addressed before its integration with routine clinical care. Objective: The main objective of this study was to examine how potential users (patients) perceive the benefits, risks, and use of AI clinical applications for their health care purposes and how their perceptions may be different if faced with three health care service encounter scenarios. Methods: We designed a 2×3 experiment that crossed a type of health condition (ie, acute or chronic) with three different types of clinical encounters between patients and physicians (ie, AI clinical applications as substituting technology, AI clinical applications as augmenting technology, and no AI as a traditional in-person visit). We used an online survey to collect data from 634 individuals in the United States. Results: The interactions between the types of health care service encounters and health conditions significantly influenced individuals' perceptions of privacy concerns, trust issues, communication barriers, concerns about transparency in regulatory standards, liability risks, benefits, and intention to use across the six scenarios. We found no significant differences among scenarios regarding perceptions of performance risk and social biases. Conclusions: The results imply that incompatibility with instrumental, technical, ethical, or regulatory values can be a reason for rejecting AI applications in health care. Thus, there are still various risks associated with implementing AI applications in diagnostics and treatment recommendations for patients with both acute and chronic illnesses. The concerns are also evident if the AI applications are used as a recommendation system under physician experience, wisdom, and control. Prior to the widespread rollout of AI, more studies are needed to identify the challenges that may raise concerns for implementing and using AI applications. This study could provide researchers and managers with critical insights into the determinants of individuals' intention to use AI clinical applications. Regulatory agencies should establish normative standards and evaluation guidelines for implementing AI in health care in cooperation with health care institutions. Regular audits and ongoing monitoring and reporting systems can be used to continuously evaluate the safety, quality, transparency, and ethical factors of AI clinical applications.
Artificial Intelligence Applications in Healthcare

Musab Aldali

DOI: https://doi.org/10.54361/ajmas.247323

2024-07-27

Abstract:Nowadays, the employment of artificial intelligence (AI) technologies in healthcare has provided useful outcomes related to decision-making, early diagnosis of diseases, and optimization of patient care services. AI technologies apply to a variety of data sources. The present paper has discussed the latest developments on Artificial Intelligence healthcare applications, AI technologies, benefits, challenges, and ethical considerations. It also has underlined the role of AI in the improvement of diagnosis, prediction, and personalized treatment. On the basis of the present research, it is claimed that the regulation of AI in healthcare is going to decide the fate of AI-ethics in healthcare for at least the coming decade. The ethical agoras on the regulation of AI-healthcare should instead stamp and remain as the imprint on possible and permissible moral and ethical philosophy of AI in healthcare shaped over the years.
Beliefs, experiences and concerns of using artificial intelligence in healthcare: A qualitative synthesis

Carol-Ann Fazakarley,Maria Breen,Ben Thompson,Paul Leeson,Victoria Williamson

DOI: https://doi.org/10.1177/20552076241230075

2024-01-01

Digital Health

Abstract:Objective Artificial intelligence (AI) is a developing field in the context of healthcare. As this technology continues to be implemented in patient care, there is a growing need to understand the thoughts and experiences of stakeholders in this area to ensure that future AI development and implementation is successful. The aim of this study was to conduct a literature search of qualitative studies exploring the opinions of stakeholders such as clinicians, patients, and technology experts in order to establish the most common themes and ideas that have been presented in this research. Methods A literature search was conducted of existing qualitative research on stakeholder beliefs about the use of AI use in healthcare. Twenty-one papers were selected and analysed resulting in the development of four key themes relating to patient care, patient–doctor relationships, lack of education and resources, and the need for regulations. Results Overall, patients and healthcare workers are open to the use of AI in care and appear positive about potential benefits. However, concerns were raised relating to the lack of empathy in interactions of AI tools, and potential risks that may arise from the data collection needed for AI use and development. Stakeholders in the healthcare, technology, and business sectors all stressed that there was a lack of appropriate education, funding, and guidelines surrounding AI, and these concerns needed to be addressed to ensure future implementation is safe and suitable for patient care. Conclusion Ultimately, the results found in this study highlighted that there was a need for communication between stakeholder in order for these concerns to be addressed, mitigate potential risks, and maximise benefits for patients and clinicians alike. The results also identified a need for further qualitative research in this area to further understand stakeholder experiences as AI use continues to develop.

public, environmental & occupational health,health care sciences & services,medical informatics,health policy & services
Experiences of using artificial intelligence in healthcare: a qualitative study of UK clinician and key stakeholder perspectives

C A Fazakarley,Maria Breen,Paul Leeson,Ben Thompson,Victoria Williamson

DOI: https://doi.org/10.1136/bmjopen-2023-076950

IF: 3.006

2023-12-11

BMJ Open

Abstract:Objectives: Artificial intelligence (AI) is a rapidly developing field in healthcare, with tools being developed across various specialties to support healthcare professionals and reduce workloads. It is important to understand the experiences of professionals working in healthcare to ensure that future AI tools are acceptable and effectively implemented. The aim of this study was to gain an in-depth understanding of the experiences and perceptions of UK healthcare workers and other key stakeholders about the use of AI in the National Health Service (NHS). Design: A qualitative study using semistructured interviews conducted remotely via MS Teams. Thematic analysis was carried out. Setting: NHS and UK higher education institutes. Participants: Thirteen participants were recruited, including clinical and non-clinical participants working for the NHS and researchers working to develop AI tools for healthcare settings. Results: Four core themes were identified: positive perceptions of AI; potential barriers to using AI in healthcare; concerns regarding AI use and steps needed to ensure the acceptability of future AI tools. Overall, we found that those working in healthcare were generally open to the use of AI and expected it to have many benefits for patients and facilitate access to care. However, concerns were raised regarding the security of patient data, the potential for misdiagnosis and that AI could increase the burden on already strained healthcare staff. Conclusion: This study found that healthcare staff are willing to engage with AI research and incorporate AI tools into care pathways. Going forward, the NHS and AI developers will need to collaborate closely to ensure that future tools are suitable for their intended use and do not negatively impact workloads or patient trust. Future AI studies should continue to incorporate the views of key stakeholders to improve tool acceptability. Trial registration number: NCT05028179; ISRCTN15113915; IRAS ref: 293515.
Exploring the Role of Artificial Intelligence in Mental Healthcare: Progress, Pitfalls, and Promises

Gemma Espejo,Wade Reiner,Michael Wenzinger

DOI: https://doi.org/10.7759/cureus.44748

2023-09-05

Cureus

Abstract:The rise of artificial intelligence (AI) heralds a significant revolution in healthcare, particularly in mental health. AI's potential spans diagnostic algorithms, data analysis from diverse sources, and real-time patient monitoring. It is essential for clinicians to remain informed about AI's progress and limitations. The inherent complexity of mental disorders, limited objective data, and retrospective studies pose challenges to the application of AI. Privacy concerns, bias, and the risk of AI replacing human care also loom. Regulatory oversight and physician involvement are needed for equitable AI implementation. AI integration and use in psychotherapy and other services are on the horizon. Patient trust, feasibility, clinical efficacy, and clinician acceptance are prerequisites. In the future, governing bodies must decide on AI ownership, governance, and integration approaches. While AI can enhance clinical decision-making and efficiency, it might also exacerbate moral dilemmas, autonomy loss, and issues regarding the scope of practice. Striking a balance between AI's strengths and limitations involves utilizing AI as a validated clinical supplement under medical supervision, necessitating active clinician involvement in AI research, ethics, and regulation. AI's trajectory must align with optimizing mental health treatment and upholding compassionate care.
The Architecture of the PCM-1

A. Sale

1990-04-01

Abstract:
Impact of Artificial Intelligence (AI) Technology in Healthcare Sector: A Critical Evaluation of Both Sides of the Coin

Ashrafur Rahman,Evangelos Victoros,Julianne Ernest,Rob Davis,Yeasna Shanjana,Rabiul Islam,Md. Ashrafur Rahman,Md. Rabiul Islam

DOI: https://doi.org/10.1177/2632010x241226887

2024-01-01

Clinical Pathology

Abstract:The influence of artificial intelligence (AI) has drastically risen in recent years, especially in the field of medicine. Its influence has spread so greatly that it is determined to become a pillar in the future medical world. A comprehensive literature search related to AI in healthcare was performed in the PubMed database and retrieved the relevant information from suitable ones. AI excels in aspects such as rapid adaptation, high diagnostic accuracy, and data management that can help improve workforce productivity. With this potential in sight, the FDA has continuously approved more machine learning (ML) software to be used by medical workers and scientists. However, there are few controversies such as increased chances of data breaches, concern for clinical implementation, and potential healthcare dilemmas. In this article, the positive and negative aspects of AI implementation in healthcare are discussed, as well as recommended some potential solutions to the potential issues at hand.
Artificial Intelligence in Medical Filed

Iram Fatima,Veena Grover,Ihtiram Raza Khan,Naved Ahmad,Ambooj Yadav

DOI: https://doi.org/10.4108/eetpht.9.4713

2023-12-29

EAI Endorsed Transactions on Pervasive Health and Technology

Abstract:In the healthcare industry artificial intelligence (AI) has become a disruptive technology that is revolutionizing patient care, diagnostics, and research. This abstract provides an overview of the main points and findings related to AI in healthcare exploring its advancements, applications, and ethical challenges. The rapid growth of AI technologies has led to remarkable improvements in healthcare. AI algorithms have demonstrated exceptional capabilities in analyzing number of patient data, enabling early disease detection, personalized treatment plans, and improved patient outcomes. Machine learning algorithms, such as deep learning and natural language processing, have been effectively employed to analyze medical images, predict disease progression, and support clinical decision-making. AI applications in healthcare span across various domains, including radiology, pathology, genomics, drug discovery, and patient monitoring. Telemedicine and AI-driven virtual health assistants have extended healthcare access to remote areas, empowering patients with self-care tools and enabling real-time communication with healthcare professionals. While it's undeniable that AI brings significant advantages to the field of healthcare, it's vital to emphasize the importance of ethical concerns. Additionally, ensuring that AI algorithms are transparent and interpretable is essential for establishing trust and promoting the responsible use of AI technology in clinical environments.
Artificial Intelligence Applications in Healthcare Sector: Ethical and Legal Challenges

Emna Chikhaoui,Alanoud Alajmi,Souad Larabi-Marie-Sainte

DOI: https://doi.org/10.28991/esj-2022-06-04-05

2022-05-29

Emerging Science Journal

Abstract:Recently, artificial intelligence (AI) has been one of the hottest topics in the technological world. Although it is involved in many domains, it was recently involved in the healthcare sector. AI can be used for diagnostics, drug development, treatment personalization, gene editing, disease prediction, and many more. It helps to improve healthcare services by benefiting medical professionals, hospitals, and patients. Saudi Arabia has a particular interest in the healthcare sector, and it has a clear vision for the future, which points toward the development of AI-based technologies. Few studies investigated the use of AI in Saudi healthcare, and most of them focused on healthcare employees' perceptions. This study is beyond the focus of the existing works. It aims at: 1) presenting the main AI-based healthcare applications; 2) exploring the use of AI in the Saudi healthcare sector; 3) addressing their ethical and legal challenges, along with the policy questions in Saudi healthcare; 4) studying the benefits of these AI-based applications and the acceptance of professionals to use AI in daily practice; 5) introducing the new Personal Data Protection Law (PDPL) in Saudi Arabia; and 6) discussing the importance of AI to the future of Saudi healthcare. To this purpose, a survey was distributed among four main Saudi hospitals. The findings showed that AI should not only lead to better health but also save manpower and simplify the healthcare processes. The respondents agreed that AI helps reflect human intellectual competencies and pushes its limits. Doi: 10.28991/ESJ-2022-06-04-05 Full Text: PDF
Artificial Intelligence and Healthcare: A Journey through History, Present Innovations, and Future Possibilities

Rahim Hirani,Kaleb Noruzi,Hassan Khuram,Anum S. Hussaini,Esewi Iyobosa Aifuwa,Kencie E. Ely,Joshua M. Lewis,Ahmed E. Gabr,Abbas Smiley,Raj K. Tiwari,Mill Etienne

DOI: https://doi.org/10.3390/life14050557

2024-04-27

Life

Abstract:Artificial intelligence (AI) has emerged as a powerful tool in healthcare significantly impacting practices from diagnostics to treatment delivery and patient management. This article examines the progress of AI in healthcare, starting from the field's inception in the 1960s to present-day innovative applications in areas such as precision medicine, robotic surgery, and drug development. In addition, the impact of the COVID-19 pandemic on the acceleration of the use of AI in technologies such as telemedicine and chatbots to enhance accessibility and improve medical education is also explored. Looking forward, the paper speculates on the promising future of AI in healthcare while critically addressing the ethical and societal considerations that accompany the integration of AI technologies. Furthermore, the potential to mitigate health disparities and the ethical implications surrounding data usage and patient privacy are discussed, emphasizing the need for evolving guidelines to govern AI's application in healthcare.

biology

Glipizide: an oral hypoglycemic drug.

Transforming Healthcare with AI: Promises, Pitfalls, and Pathways Forward

Exploring the Potential of Artificial Intelligence in Healthcare: Possibilities and Challenges

Association of serum lipid profiles with depressive and anxiety disorders in menopausal women.

Legal and Ethical Challenges of Artificial Intelligence Applications in Healthcare

Artificial Intelligence in Health Sector: Current Status and Future Perspectives

Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives

What kills patients with rheumatoid arthritis?

Artificial Intelligence in Healthcare With an Emphasis on Public Health

Artificial Intelligence in Medicine: Revolutionizing Healthcare for Improved Patient Outcomes

Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges

Patients' Perceptions Toward Human-Artificial Intelligence Interaction in Health Care: Experimental Study

Artificial Intelligence Applications in Healthcare

Beliefs, experiences and concerns of using artificial intelligence in healthcare: A qualitative synthesis

Experiences of using artificial intelligence in healthcare: a qualitative study of UK clinician and key stakeholder perspectives

Exploring the Role of Artificial Intelligence in Mental Healthcare: Progress, Pitfalls, and Promises

The Architecture of the PCM-1

Impact of Artificial Intelligence (AI) Technology in Healthcare Sector: A Critical Evaluation of Both Sides of the Coin

Artificial Intelligence in Medical Filed

Artificial Intelligence Applications in Healthcare Sector: Ethical and Legal Challenges

Artificial Intelligence and Healthcare: A Journey through History, Present Innovations, and Future Possibilities